What is the Current Share Price of Marksans Pharma Ltd?
- Answer Field
-
Marksans Pharma Ltd share price is for NSE ₹ 256.07 & for BSE ₹ 256.10 as on Jun 25 2026 03:30 PM.
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
MARKSANS PHARMA LIMITED is currently trading at ₹256.07, down by ₹6.94 from the previous close. The stock touched an intraday high of ₹265.85 and a low of ₹253.60 during the latest trading session. Over the past one year, MARKSANS PHARMA LIMITED has delivered a return of 3.67%, while the stock has gained 16.25% in the last one month.
| Particulars | MAR 2026 (Values in Cr) |
|---|---|
| Revenue | 361.57 |
| Operating Expense | 264.69 |
| Net Profit | 91.92 |
| Net Profit Margin (%) | 25.42 |
| Earnings Per Share (EPS) | 2.03 |
| EBITDA | 133.47 |
| Effective Tax Rate (%) | 26.08 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 31.51 | 13.02 | 1.52 | 241.47 | 23.12 | 38.85 |
| BLISS GVS PHARMA LTD. | 492.50 | 39.98 | 4.37 | 5223.27 | 118.35 | 495.00 |
| CIPLA LTD. | 1440.30 | 30.57 | 3.37 | 116353.96 | 1165.55 | 1672.20 |
| FERMENTA BIOTECH LTD. | 365.50 | 16.12 | 2.64 | 1075.70 | 256.40 | 399.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 31.51 | 22.03 | 4.05 | 241.47 | 23.12 | 38.85 |
| AMRUTAJAN HEALTH LTD | 538.05 | 24.12 | 4.20 | 1555.54 | 490.00 | 789.95 |
| ASTRAZENECA PHARMA INDIA LTD. | 8382.65 | 109.48 | 24.01 | 20956.63 | 7630.00 | 9850.00 |
| BLISS GVS PHARMA LTD. | 492.50 | 53.13 | 4.52 | 5223.27 | 118.35 | 495.00 |
Particulars | Sep 2024 (₹ in Cr) | Jun 2024 (₹ in Cr) | Mar 2024 (₹ in Cr) | Dec 2023 (₹ in Cr) | Sep 2023 (₹ in Cr) |
Revenue | 308.63 | 254.53 | 225.20 | 241.36 | 204.67 |
Operating Expense | 263.65 | 220.38 | 198.98 | 208.09 | 176.10 |
Net Profit | 63.20 | 32.02 | 32.99 | 25.29 | 31.29 |
Net Profit Margin (%) | 20.47 | 12.58 | 14.64 | 10.47 | 15.28 |
Earnings Per Share (₹) | 1.39 | 0.71 | 0.73 | 0.56 | 0.69 |
EBITDA | 83.64 | 49.42 | 46.09 | 43.30 | 53.23 |
Effective Tax Rate (%) | 17.19 | 24.30 | 14.08 | 26.90 | 29.68 |
Key Highlights:
Particulars | Mar 2024 (₹ in Cr) | Mar 2023 (₹ in Cr) |
Revenue | 853.27 | 732.00 |
Operating Expense | 743.46 | 650.23 |
Net Profit | 133.76 | 112.65 |
Net Profit Margin (%) | 15.67 | 15.39 |
Earnings Per Share (₹) | 2.95 | 2.50 |
EBITDA | 202.01 | 180.52 |
Effective Tax Rate (%) | 22.18 | 20.50 |
Key Highlights:
Particulars | Ex-Date | Record Date |
Dividend per Share (₹) | 07 Jun, 2023 | 07 Jun, 2023 |
Dividend Yield (%) | 0.5 | Equity Shares |
Key Highlights:
Who is the CEO of Marksans Pharma Ltd?
Marksans Pharma Ltd is led by Mr. Mark Saldanha, who serves as the Managing Director and Chief Executive Officer of the company. Under his leadership, the company has expanded its presence in the global pharmaceutical market and achieved significant growth in various regions. Mr. Saldanha’s vision has been instrumental in driving the company’s strategic acquisitions, as well as in its research and development initiatives.
When was Marksans Pharma established?
Marksans Pharma Ltd was initially incorporated as Tasc Pharmaceuticals Limited in April 1982. Following a Scheme of Amalgamation, the company’s name was changed to Marksans Pharma Ltd on 10th October 2005. The rebranding marked the beginning of the company’s expanded focus on pharmaceutical formulations, and since then, it has become a prominent player in the pharmaceutical sector.
What factors influence the Marksans Pharma Share Price?
The Marksans Pharma share price is influenced by several key factors, including:
Is Marksans Pharma debt-free?
Marksans Pharma Ltd is not entirely debt-free. However, the company has maintained a manageable level of debt as part of its capital structure. It strategically acquires businesses and invests in research and development to fuel its growth. The debt levels are often monitored to ensure they do not adversely impact the company's financial health. Despite this, the company has successfully maintained profitability and strong cash flow, helping it manage its liabilities efficiently.
What is the CAGR of Marksans Pharma Share?
The Marksans Pharma share price has demonstrated a Compound Annual Growth Rate (CAGR) of:
This impressive growth rate highlights the company’s consistent performance and the market’s positive response to its strategic initiatives, including acquisitions and expanding its product portfolio.
How has the Marksans Pharma Share Price performed over the past year?
Over the past year, the Marksans Pharma share price has seen a remarkable increase of 96%. This surge in share price reflects strong financial performance, successful product approvals, and the company's continued expansion in both domestic and international markets. The robust growth in the past year has also been fueled by investor confidence, supported by strategic acquisitions such as Tevapharm India and the company's increasing presence in the global pharmaceutical industry.
Sign-in to trade with your demat account, or set up a new demat account for free
Marksans Pharma Ltd share price is for NSE ₹ 256.07 & for BSE ₹ 256.10 as on Jun 25 2026 03:30 PM.
The market cap of Marksans Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 25 2026 03:30 PM.
The 52 Week High and Low of Marksans Pharma Ltd for NSE is ₹ 275.50 and ₹ 155.00 and for BSE is ₹ 275.25 and ₹ 156.00.
The 1 year returns on the stock has been 3.67%.
As on Jun 25 2026 03:30 PM the price-to-earnings (PE) ratio for Marksans Pharma Ltd share is 38.57.
As on Jun 25 2026 03:30 PM, the price-to-book (PB) ratio for Marksans Pharma Ltd share is 36.46.
You can trade in Marksans Pharma Ltd shares with Bajaj Broking by opening a demat account.
To buy Marksans Pharma Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Marksans Pharma Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found